The Patent Finder

Talon Therapeutics, Inc.

Also on record
Records under this name other than patents Talon Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Talon Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,815,953Formulations of Vitamin K Analogs for Topical Use
Lapsed on the fee record
Ended Aug 26, 2026 · High confidence
Lapsed on the fee recordEnded Aug 26, 2026High confidence
US 9,801,874Method for the Preparation of Liposome Encapsulated Vincristine for Therapeutic Use
Formerly held
Lapsed on the fee record
Ended Oct 31, 2025 · High confidence
Lapsed on the fee recordEnded Oct 31, 2025High confidence
US 7,244,450Compositions and Methods for Treating Lymphoma
Formerly held
Term ended
Ended no later than Mar 6, 2022 · Low confidence
Term endedEnded no later than Mar 6, 2022Low confidence
US 7,311,924Compositions and Methods for Treating Cancer
Term ended
Term ended Nov 14, 2021 · Medium confidence
Term endedTerm ended Nov 14, 2021Medium confidence
US 7,060,828Liposomal Camptothecins and Uses Thereof
Term ended
Term ended Jun 29, 2021 · High confidence
Term endedTerm ended Jun 29, 2021High confidence
US 7,244,448Liposomal Antineoplastic Drugs and Uses Thereof
Term ended
Term ended Jun 29, 2021 · High confidence
Term endedTerm ended Jun 29, 2021High confidence
US 7,452,550Liposomal Antineoplastic Drugs and Uses Thereof
Term ended
Term ended Jun 29, 2021 · High confidence
Term endedTerm ended Jun 29, 2021High confidence
US 7,887,836Compositions and Methods for Treating Lymphoma
Formerly held
Term ended
Ended no later than Apr 5, 2021 · Low confidence
Term endedEnded no later than Apr 5, 2021Low confidence
US 7,247,316Compositions and Methods for Treating Lymphoma
Formerly held
Term ended
Term ended Sep 28, 2020 · Medium confidence
Term endedTerm ended Sep 28, 2020Medium confidence
US 6,723,338Compositions and methods for treating lymphoma
Formerly held
Term ended
Term ended Mar 31, 2020 · USPTO record
Term endedTerm ended Mar 31, 2020USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited